Screening of pharmacogenetic variants associated with drug sensitivity in patients with papillary thyroid carcinoma using next generation sequencing

Screening of pharmacogenetic variants associated with drug sensitivity in patients with papillary thyroid carcinoma using next generation sequencing

Thyroid cancer is the most common malignant tumour of the endocrine system. One of the most frequent types of thyroid malignancy is papillary carcinoma. In our study, we performed next generation sequencing (NGS) using a cancer panel (Illumina; Illumina, San Diego, USA) to screen for pharmacogenetic...

Full description

Bibliographic Details
Main Authors: Zora Hammoudeh, Dragomira Nikolova, Lubomir Balabanski, Samuil Ivanov, Radoslava Vazharova, Sabine Weidner, Maxim Malinov, Draga Toncheva
Format: Article
Language:English
Published: Taylor & Francis Group 2017-07-01
Series:Biotechnology & Biotechnological Equipment
Subjects:
Papillary thyroid cancer (PTC)
drug sensitivity
next generation sequencing (NGS)
pharmacogenetic variants
Online Access:http://dx.doi.org/10.1080/13102818.2017.1335614

Internet

http://dx.doi.org/10.1080/13102818.2017.1335614

Similar Items